Europe Clinical Nutrition Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Europe Clinical Nutrition Market is segmented By Route of Administration (Oral and Enteral, Parenteral), By Application (Nutritional Support for Malnutrition, Nutritional Support for Metabolic Disorders, Nutritional Support for Gastrointestinal Diseases, Nutritional Support for Cancer, Nutritional Support in Neurological Diseases and Nutritional Support in Other Diseases, By End User (Pediatric and Adult) and Country. The report offers the value (in USD million) for the above segments.

Market Snapshot

Europe Clinical Nutrition Market_1
Study Period: 2019-2027
Base Year: 2021
CAGR: 6.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Europe Clinical Nutrition Market is expected to register a CAGR of 6.2% during the forecast period (2022-2027).

COVID-19 infection has become a major public health concern, and clinical nutrition plays a crucial role in preventing infection and treating infection-associated malnutrition. For instance, the in July 2020 European Society for Clinical Nutrition and Metabolism issued guidelines related to nutritional management in ICU patients infected with COVID-19. Thus, a positive impact can be expected on the market studied due to COVID-19.

The major factors attributing to the growth of the market are increasing the prevalence of metabolic disorders, and high spending on healthcare. For instance, according to the 2022 statistics published by the International Diabetes Federation (IDF) Diabetes Atlas, an estimated 61 million adults (20-79 years old) in the International Diabetes Federation Europe region had diabetes in 2021. In addition, as per the same source, 295,000 children and adolescents (0-19 years) in the region have type 1 diabetes. Thus, the increasing burden of diabetes in the region is expected to increase the demand for dietary therapy, thereby boosting the market growth.

In addition, according to the Europe 2021 Aging Report, 21% of the Europe population was aged 65 years or above and this number is projected to increase by 14% by 2100. Thus, the increasing number of the geriatric population who are more prone to develop metabolic disorders is likely to increase the demand for nutrition therapy to prevent acute complications, such as metabolic decompensation, and/or to prevent long-term complications of the given disorder, which is expected to augment the market growth over the forecast period.

Furthermore, the increasing government initiatives in launching guidelines and aware people regarding clinical nutrition are also contributing to the growth of the market. For instance, in June 2020, the European Society for Clinical Nutrition and Management launched its guideline on clinical nutrition in inflammatory bowel disease (IBD) as an app version for smartphones and tablets for professionals (physicians, nurses, dieticians, nutritionists, etc).

However, the unwillingness of hospitals and in-house pharmacies/ dispensaries to maintain the required stock of clinical nutrition products and imprecise perception about clinical nutrition are likely to restrain the market growth over the forecast period.

Scope of the Report

As per the scope of the report, clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than supplements. Clinical nutrition is largely concerned with the prevention, diagnosis, and management of nutritional alterations in individuals who have chronic illnesses and disorders. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. The Europe Clinical Nutrition Market is segmented By Route of Administration (Oral and Enteral, Parenteral), By Application (Nutritional Support for Malnutrition, Nutritional Support for Metabolic Disorders, Nutritional Support for Gastrointestinal Diseases, Nutritional Support for Cancer, Nutritional Support in Neurological Diseases and Nutritional Support in Other Diseases, By End User (Pediatric and Adult) and Country. The report offers the value (in USD million) for the above segments.

By Route of Administration
Oral and Enteral
Parenteral
By Application
Nutritional Support for Malnutrition
Nutritional Support for Metabolic Disorders
Nutritional Support for Gastrointestinal Diseases
Nutritional Support for Cancer
Nutritional Support in Neurological Diseases?
Nutritional Support in Other Diseases
By End User
Pediatric
Adult
Geography
Germany
United Kingdom
France
Italy
Spain
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Nutritional Support for Metabolic Disorders Segment Expects to Register a High CAGR in the Forecast Period

The nutritional support for the metabolic disorders segment is expected to witness significant growth over the forecast period owing to the factors such as the rising prevalence of metabolic disorders such as diabetes, liver diseases, cardiovascular diseases, and others among the population. For instance, according to International Diabetes Federation Atlas 2021 Fact Sheet, it has been found that 61 million adults have diabetes in the region and 36% of the adults living with diabetes are undiagnosed. As per the same source, the prevalence of diabetes in the population aged between 20 years to 79 years was 9.2% in 2021 and it is projected that the prevalence rate will increase to 9.8% in 2030 and 10.4% in 2045. Thus, the increasing burden of diabetes among the population is expected to increase the demand for nutrition therapy to control blood sugar (glucose), manage weight to reduce heart-related risks such as high blood pressure and high blood fats, which is expected to augment the market growth over the forecast period.

In addition, the rising geriatric population in the region is also contributing to the growth of the market. For instance, as per Germany Federal Statistical Office 2020 report, currently, there is about 83 million population in Germany out of which 16.2 million population are above 67 years of age, and this number is projected to reach 21.4 million in 2040. The number of elderly population is expected to increase in the near future who are more prone to metabolic, neurological, and other disorders, which is expected to increase the demand for nutrition therapy, thereby propelling the market growth over the forecast period.

Furthermore, the increasing company activities for providing nutrition products to the people in the region are expected to increase the demand for clinical nutritional products, thereby boosting the market growth. For instance, in March 2022, Cymbiotika launched a new e-commerce store in the United Kingdom that offers quick access to Cymbiotika's rapidly growing line of natural supplements. Similarly, in July 2021, Vitafoods Europe, Omya launched Omyanutra 300 DC and 300 Flash for nutraceutical tablets. 

Thus, the increasing burden of metabolic disorders, growing geriatric population, and rising company activities in the region are expected to increase the demand for clinical nutrition therapy and products to reduce the risks of developing chronic diseases, which is expected to augment the market growth over the forecast period.

123

Competitive Landscape

The Europe clinical nutrition market is consolidated and competitive and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. Factors such as the increasing prevalence of metabolic diseases the market is expected to grow furthermore. Hence, few other players are expected to penetrate the market in the coming years. Some of the major players in the market are Abbott Nutrition, Nestle Health Science, Baxter Healthcare, B. Braun Melsungen AG, and Danone S.A. (Nutricia) among others.

Recent Development

In April 2022, Glanbia Nutritionals launched TechVantage at the nutraceutical event Vitafoods Europe. TechVantage will provide customers with nutrient solutions with stability enhancements, the ability to mask flavors/colors, and solubility/flowability improvements.

In January 2022, World Health Organization/Europe launched a new, voluntary, Member State-led Sugar and Calorie Reduction Network to promote healthier diets as well as reduce overweight and obesity levels across the World Health Organization European Region.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Metabolic Disorders

      2. 4.2.2 High Spending on Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Unwillingness of Hospitals and In-house Pharmacies/ Dispensaries to Maintain the Required Stock of Clinical Nutrition Products

      2. 4.3.2 Imprecise Perception about Clinical Nutrition

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Route of Administration

      1. 5.1.1 Oral and Enteral

      2. 5.1.2 Parenteral

    2. 5.2 By Application

      1. 5.2.1 Nutritional Support for Malnutrition

      2. 5.2.2 Nutritional Support for Metabolic Disorders

      3. 5.2.3 Nutritional Support for Gastrointestinal Diseases

      4. 5.2.4 Nutritional Support for Cancer

      5. 5.2.5 Nutritional Support in Neurological Diseases?

      6. 5.2.6 Nutritional Support in Other Diseases

    3. 5.3 By End User

      1. 5.3.1 Pediatric

      2. 5.3.2 Adult

    4. 5.4 Geography

      1. 5.4.1 Germany

      2. 5.4.2 United Kingdom

      3. 5.4.3 France

      4. 5.4.4 Italy

      5. 5.4.5 Spain

      6. 5.4.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Nutrition

      2. 6.1.2 Nestle Health Science

      3. 6.1.3 Baxter Healthcare

      4. 6.1.4 B. Braun Melsungen AG

      5. 6.1.5 Danone S.A. (Nutricia)

      6. 6.1.6 Reckitt Benckiser Group PLC (Mead Johnson)

      7. 6.1.7 Perrigo Company PLC

      8. 6.1.8 Fresenius Kabi

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Clinical Nutrition Market market is studied from 2019 - 2027.

The Europe Clinical Nutrition Market is growing at a CAGR of 6.2% over the next 5 years.

Abbott Nutrition, Nestle Health Science, B. Braun Melsungen AG, Baxter Healthcare, Danone S.A. (Nutricia) are the major companies operating in Europe Clinical Nutrition Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!